Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report

Fig. 1

Computed tomography (CT) and positron emission tomography-computed tomography (PET-CT) course. Two months after right cervical dissection for right submandibular lymph node metastasis, computed tomography revealed right cervical recurrence and lung metastasis (A), positron emission tomography-computed tomography demonstrated multiple cervical metastases (B), and skin erythema associated with tumor invasion (C). Five months after initiation of pembrolizumab therapy, computed tomography revealed marked shrinkage of the tumor (D), which was evaluated as complete remission (CR), and skin erythema was absent (E)

Back to article page